511 related articles for article (PubMed ID: 4038714)
1. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
3. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
4. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
McElduff A; Posen S
J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets.
Cowgill LD; Goldfarb S; Lau K; Slatopolsky E; Agus ZS
J Clin Invest; 1979 Jun; 63(6):1203-10. PubMed ID: 221535
[TBL] [Abstract][Full Text] [Related]
8. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
Short E; Morris RC; Sebastian A; Spencer M
J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
[TBL] [Abstract][Full Text] [Related]
9. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
[TBL] [Abstract][Full Text] [Related]
10. Serum parathyroid hormone in X-linked hypophosphatemia.
Arnaud C; Glorieux F; Scriver C
Science; 1971 Aug; 173(3999):845-7. PubMed ID: 5315247
[TBL] [Abstract][Full Text] [Related]
11. Hereditary hypophosphatemic rickets with hypercalciuria.
Tieder M; Modai D; Samuel R; Arie R; Halabe A; Bab I; Gabizon D; Liberman UA
N Engl J Med; 1985 Mar; 312(10):611-7. PubMed ID: 2983203
[TBL] [Abstract][Full Text] [Related]
12. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
13. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
14. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
Lyles KW; Halsey DL; Friedman NE; Lobaugh B
J Clin Endocrinol Metab; 1988 Jul; 67(1):88-92. PubMed ID: 3379139
[TBL] [Abstract][Full Text] [Related]
15. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
Madsen S; Olgaard K
Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
[TBL] [Abstract][Full Text] [Related]
16. Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes.
Arcidiacono GP; Camozzi V; Zaninotto M; Tripepi G; Fusaro M; Torres MO; Zanchetta F; Cannito M; Cecchinato A; Diogo M; Peleg Falb M; Plebani M; Simioni P; Sella S; Giannini S
Clin Chem Lab Med; 2024 May; 62(6):1126-1132. PubMed ID: 38295343
[TBL] [Abstract][Full Text] [Related]
17. [Hypophosphatemia of a genetic origin].
Escoubet B; Silve C
Nephrologie; 1992; 13(3):115-21. PubMed ID: 1641053
[TBL] [Abstract][Full Text] [Related]
18. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
Alon U; Newsome H; Chan JC
Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
20. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]